Structure of the Type IX Group BStreptococcusCapsular Polysaccharide and Its Evolutionary Relationship with Types V and VII

Exploring the Group B Streptococcus capsular polysaccharides: The structural diversity provides the basis for development of NMR-based identity assays

(2014) Vittoria Pinto et al.   JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

Emerging Trends in the Epidemiology of Invasive Group B Streptococcal Disease in England and Wales, 1991–2010

(2013) Theresa L. Lamagni et al.   CLINICAL INFECTIOUS DISEASES

An overview of global GBS epidemiology

(2013) Kirsty Le Doare et al.   VACCINE

Group B streptococcal epidemiology and vaccine needs in developed countries

(2013) Pierrette Melin et al.   VACCINE

Capsular Gene Typing of Streptococcus agalactiae Compared to Serotyping by Latex Agglutination

(2012) K. Yao et al.   JOURNAL OF CLINICAL MICROBIOLOGY

The immune response to group B streptococcus type III capsular polysaccharide is directed to the -Glc-GlcNAc-Gal- backbone epitope

(2011) Dodi Safari et al.   GLYCOCONJUGATE JOURNAL

Group B streptococcal conjugate vaccine: A timely concept for which the time has come

(2011) Morven S. Edwards   Human vaccines & immunotherapeutics

A multiplex PCR assay for the direct identification of the capsular type (Ia to IX) of Streptococcus agalactiae

(2009) Monica Imperi et al.   JOURNAL OF MICROBIOLOGICAL METHODS

Assignment of Streptococcus agalactiae isolates to clonal complexes using a small set of single nucleotide polymorphisms

(2008) Erin Honsa et al.   BMC MICROBIOLOGY

Rational chemical design of the carbohydrate in a glycoconjugate vaccine enhances IgM-to-IgG switching

(2008) H.-K. Guttormsen et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA